Format
Sort by
Items per page

Send to

Choose Destination

Best matches for antipsychotic agents AND psychoses, substance-induced AND psychotic disorders AND schizophrenia:

Alcohol-induced psychotic disorder: a review. Jordaan GP et al. Metab Brain Dis. (2014)

Psychosis in children and youth: focus on early-onset schizophrenia. Abidi S et al. Pediatr Rev. (2013)

Psychoses in the elderly: a spectrum of disorders. Targum SD et al. J Clin Psychiatry. (1999)

Search results

Items: 1 to 20 of 228

1.

Antipsychotic-Induced Dopamine Supersensitivity Psychosis: Pharmacology, Criteria, and Therapy.

Chouinard G, Samaha AN, Chouinard VA, Peretti CS, Kanahara N, Takase M, Iyo M.

Psychother Psychosom. 2017;86(4):189-219. doi: 10.1159/000477313. Epub 2017 Jun 24. Review.

2.

Efficacy of clozapine on dopamine supersensitivity psychosis in schizophrenia.

Nakata Y, Kanahara N, Kimura H, Watanabe H, Iyo M.

Int Clin Psychopharmacol. 2017 May;32(3):169-173. doi: 10.1097/YIC.0000000000000160.

PMID:
28067751
3.

Psychosis After Switch in Opioid Maintenance Agonist and Risperidone-Induced Pisa Syndrome: Two Critical Incidents in Dual Diagnosis Treatment.

Sutter M Md, Walter M, Dürsteler KM, Strasser J, Vogel M.

J Dual Diagn. 2017 Apr-Jun;13(2):157-165. doi: 10.1080/15504263.2016.1269224. Epub 2016 Dec 9.

PMID:
27935442
4.

Risperidone long-acting injectable in the treatment of treatment-resistant schizophrenia with dopamine supersensitivity psychosis: Results of a 2-year prospective study, including an additional 1-year follow-up.

Kimura H, Kanahara N, Sasaki T, Komatsu N, Ishige M, Muneoka K, Ino H, Yoshimura K, Yamanaka H, Suzuki T, Komatsu H, Watanabe H, Shimizu E, Iyo M.

J Psychopharmacol. 2016 Aug;30(8):795-802. doi: 10.1177/0269881116655978. Epub 2016 Jul 1.

PMID:
27371496
5.
6.

Impact of dopamine supersensitivity psychosis in treatment-resistant schizophrenia: An analysis of multi-factors predicting long-term prognosis.

Yamanaka H, Kanahara N, Suzuki T, Takase M, Moriyama T, Watanabe H, Hirata T, Asano M, Iyo M.

Schizophr Res. 2016 Feb;170(2-3):252-8. doi: 10.1016/j.schres.2016.01.013. Epub 2016 Jan 13.

PMID:
26775264
7.

Atypical course in severe catatonic schizophrenia in a cannabis-dependent male adolescent: a case report.

HÃ¥kansson A, Johansson BA.

J Med Case Rep. 2015 Sep 21;9:200. doi: 10.1186/s13256-015-0678-5.

8.

Mephentermine dependence syndrome - A new emerging trend of substance use.

Gowda GS, Singh A, Ravi M, Math SB.

Asian J Psychiatr. 2015 Oct;17:101-2. doi: 10.1016/j.ajp.2015.07.006. Epub 2015 Jul 20. No abstract available.

PMID:
26236018
9.

Efficacy and Safety of Cariprazine in Acute Exacerbation of Schizophrenia: Results From an International, Phase III Clinical Trial.

Kane JM, Zukin S, Wang Y, Lu K, Ruth A, Nagy K, Laszlovszky I, Durgam S.

J Clin Psychopharmacol. 2015 Aug;35(4):367-73. doi: 10.1097/JCP.0000000000000346.

PMID:
26075487
10.

Dopamine supersensitivity psychosis as a pivotal factor in treatment-resistant schizophrenia.

Suzuki T, Kanahara N, Yamanaka H, Takase M, Kimura H, Watanabe H, Iyo M.

Psychiatry Res. 2015 Jun 30;227(2-3):278-82. doi: 10.1016/j.psychres.2015.02.021. Epub 2015 Mar 31.

PMID:
25863824
11.

Caffeine-induced psychiatric manifestations: a review.

Wang HR, Woo YS, Bahk WM.

Int Clin Psychopharmacol. 2015 Jul;30(4):179-82. doi: 10.1097/YIC.0000000000000076. Review.

PMID:
25856116
12.

Dopamine supersensitivity psychosis and dopamine partial agonist: a retrospective survey of failure of switching to aripiprazole in schizophrenia.

Takase M, Kanahara N, Oda Y, Kimura H, Watanabe H, Iyo M.

J Psychopharmacol. 2015 Apr;29(4):383-9. doi: 10.1177/0269881115570083. Epub 2015 Mar 3.

13.

The Psychotic Couple--Sharing Drugs or Delusions?

Springs J.

J S C Med Assoc. 2015 Jan;110(4):149-50.

PMID:
27141698
14.

Paliperidone for the treatment of ketamine-induced psychosis: a case report.

Zuccoli ML, Muscella A, Fucile C, Carrozzino R, Mattioli F, Martelli A, Orengo S.

Int J Psychiatry Med. 2014;48(2):103-8. doi: 10.2190/PM.48.2.c.

PMID:
25377151
15.

Treatment of refractory substance-induced psychosis in adolescent males with a genetic predisposition to mental illness.

Rahmani M, Paul S, Nguyen ML.

Int J Adolesc Med Health. 2014;26(2):297-301. doi: 10.1515/ijamh-2013-0505.

PMID:
24762642
16.

Alcohol-induced psychotic disorder: a review.

Jordaan GP, Emsley R.

Metab Brain Dis. 2014 Jun;29(2):231-43. doi: 10.1007/s11011-013-9457-4. Epub 2013 Dec 5. Review.

PMID:
24307180
17.

Psychosis in children and youth: focus on early-onset schizophrenia.

Abidi S.

Pediatr Rev. 2013 Jul;34(7):296-305; quiz 305-6. doi: 10.1542/pir.34-7-296. Review.

PMID:
23818084
18.

A systematic review of reported cases involving psychotic symptoms worsened by aripiprazole in schizophrenia or schizoaffective disorder.

Takeuchi H, Remington G.

Psychopharmacology (Berl). 2013 Jul;228(2):175-85. doi: 10.1007/s00213-013-3154-1. Epub 2013 Jun 5. Review.

PMID:
23736279
19.

Aripiprazole for treating cannabis-induced psychotic symptoms in ultrahigh-risk individuals.

Rolland B, Geoffroy PA, Jardri R, Cottencin O.

Clin Neuropharmacol. 2013 May-Jun;36(3):98-9. doi: 10.1097/WNF.0b013e3182908330.

PMID:
23673914

Supplemental Content

Loading ...
Support Center